Education
About Us
Working with TipRanks
Follow Us
Melodiol Global Health Limited (DE:1X80)
FRANKFURT:1X80
1X80 Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume3.00
Average Volume (3M)N/A
Market Cap
$676.84K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Melodiol Global Health News
PremiumCompany Announcements
Melodiol Global Health Ceases Securities Post Expiry
PremiumCompany Announcements
Melodiol Global Health’s Options Expire UnexercisedPremiumCompany Announcements
Melodiol Global Health Options Expire Unexercised
PremiumCompany Announcements
Melodiol’s Options to Expire Amid Low Stock Price
PremiumCompany Announcements
Melodiol Director’s Interest Altered by Option Expiry
PremiumCompany Announcements
Melodiol Global Health Options Expire UnexercisedPremiumCompany Announcements
Melodiol Issues New Shares, Ensures Compliance
PremiumCompany Announcements
Melodiol Global Health Expands Capital Base1X80 FAQ
What was Melodiol Global Health Limited’s price range in the past 12 months?
Currently, no data Available
What is Melodiol Global Health Limited’s market cap?
Melodiol Global Health Limited’s market cap is $676.84K.
When is Melodiol Global Health Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Melodiol Global Health Limited’s earnings last quarter?
Currently, no data Available
Is Melodiol Global Health Limited overvalued?
According to Wall Street analysts Melodiol Global Health Limited’s price is currently Overvalued.
Does Melodiol Global Health Limited pay dividends?
Melodiol Global Health Limited does not currently pay dividends.
What is Melodiol Global Health Limited’s EPS estimate?
Melodiol Global Health Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Melodiol Global Health Limited have?
Currently, no data Available
What happened to Melodiol Global Health Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Melodiol Global Health Limited?
Currently, no hedge funds are holding shares in DE:1X80
Melodiol Global Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
Melodiol Global Health Limited
Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe and Middle East regions.
Technical Analysis
Melodiol Global Health
―
Medical Marijuana
―
CV Sciences
―
AXIM Biotechnologies
―
Auxly Cannabis Group
―
Aurora Cannabis
―
Pfizer
―